Skip to main content
. 2017 Mar 12;2017:5952897. doi: 10.1155/2017/5952897

Table 4.

Effect of M. inermis in scopolamine-induced cognitive deficit mice in ORT.

Treatments Exploration time (seconds) Discrimination index
Session 1 Session 2
N F
H2O + Scop 31.4 ± 2.1 21.2 ± 0.64c 18 ± 1.2c 0.08c
39.3 + Scop 38.2 ± 1.8 36.2 ± 3.0∗∗∗ 13.8 ± 0.7∗∗ 0.45
98.25 + Scop 34.8 ± 2.6 38.0 ± 1.6∗∗∗ 11.4 ± 1.3∗∗∗ 0.54∗∗∗
196.5 + Scop 38.0 ± 3.6 40.2 ± 3.0∗∗∗ 9.6 ± 1.9∗∗∗ 0.61∗∗∗
393 + Scop 32.0 ± 3.2 32.0 ± 2.8∗∗∗ 10.8 ± 1.4∗∗∗ 0.49∗∗
Pira + Scop 33.0 ± 2.8 35.4 ± 2.5∗∗∗ 11.8 ± 1.5∗∗∗ 0.50∗∗∗
H2O + H2O 30.0 ± 1.6 36.0 ± 3.6∗∗∗ 11.2 ± 1.1∗∗∗ 0.52∗∗∗

Data are mean ± SD, n = 5 per dose. P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001, compared to scopolamine-treated group (H2O + Scop), one-way ANOVA followed by Dunnett's bilateral comparisons for exploration time, and Duncan's test for discrimination index. cP < 0.001 compared to normal control group (H2O + H2O), one-way ANOVA followed by Dunnett's bilateral comparisons for exploration time, and Duncan's test for discrimination index. F: familiar object, H2O: distilled water, N: novel object, Pira: piracetam 200 mg/kg, Scop: scopolamine 0.4 mg/kg.